1-15 of 15
Qinglin Pei
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

AHOD2131: A Randomized Phase 3 Response-Adapted Trial Comparing Standard Therapy with Immuno-Oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma

Tara O. Henderson, Boyu Hu, Frank Keller, Qinglin Pei, Yue Wu, Bradford Hoppe, Sarah Milgrom, Song Yao, Niloufer Khan, Lisa Giulino Roth, Raymond Mailhot, Steve Cho, Susan K Parsons, Justine M. Kahn, Adam S Duvall, Pamela S. Hinds, Ann LaCasce, Natalie S. Grover, Pamela B. Allen, Andrew M Evens, Heiko Schoder, Sharon M. Castellino, Kara M. Kelly
Journal: Blood
Blood (2023) 142 (Supplement 1): 3084.
https://doi.org/10.1182/blood-2023-189652
Published: 2023
Journal Articles

Identifying Tumor-Specific Immune Response and Biomarkers of High-Risk Hodgkin Lymphoma Patients Treated with and without Brentuximab on Children's Oncology Group Trial AHOD1331

Keri Toner, Hema Dave, Gloria Pezzella, Qinglin Pei, Terzah M. Horton, Kara M. Kelly, Lisa Giulino Roth, Sharon M. Castellino, Catherine M. Bollard
Journal: Blood
Blood (2023) 142 (Supplement 1): 4383.
https://doi.org/10.1182/blood-2023-180791
Published: 2023
Journal Articles

Performance of Positron Emission Tomography at Diagnosis and Response Assessment in Low and Intermediate-Risk Nodular Lymphocyte Predominant Hodgkin Lymphoma

Lianna J. Marks, Kathleen McCarten, Qinglin Pei, Yue Wu, Kara M. Kelly, Cindy Schwartz, Suzanne Wolden, Debra L. Friedman, Sharon M. Castellino, Burton Appel
Journal: Blood
Blood (2023) 142 (Supplement 1): 1699.
https://doi.org/10.1182/blood-2023-179465
Published: 2023
Journal Articles

Longitudinal Differences By Treatment Arm in Health-Related Quality of Life Among High Risk Pediatric Hodgkin's Lymphoma Patients Treated on the Children's Oncology Group Ahod 1331 Study

Annalynn M Williams, Angie Mae Rodday, Qinglin Pei, Tara O. Henderson, Frank Keller, Angela Punnett, Kara M. Kelly, Sharon M. Castellino, Susan K Parsons
Journal: Blood
Blood (2023) 142 (Supplement 1): 672.
https://doi.org/10.1182/blood-2023-187125
Published: 2023
Journal Articles

Evaluating CHIPS in Pediatric High Risk Hodgkin Lymphoma Treated on AHOD1331

Cindy L Schwartz, Qinglin Pei, Frank G. Keller, Steve Y Cho, David C. Hodgson, Kathleen M McCarten, Yue Wu, Kara M. Kelly, Sharon M. Castellino
Journal: Blood
Blood (2022) 140 (Supplement 1): 6565–6566.
https://doi.org/10.1182/blood-2022-167188
Published: 2022
Journal Articles

Peripheral Neuropathy in Children with High Risk Hodgkin Lymphoma (HL): The Role of Protocol-Stipulated Dose Modification in the Children's Oncology Group (COG) AHOD1331 Study

Susan K. Parsons, Frank G. Keller, Qinglin Pei, Angie Mae Rodday, Jennifer Belsky, Yue Wu, Angela Punnett, Tara O Henderson, Kara M. Kelly, Sharon M. Castellino
Journal: Blood
Blood (2022) 140 (Supplement 1): 6550–6551.
https://doi.org/10.1182/blood-2022-167046
Published: 2022
Journal Articles

Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysis

Clinical Trials & Observations
Akash Parekh, Frank G. Keller, Kathleen M. McCarten, Sandy Kessel, Steve Cho, Qinglin Pei, Yue Wu, Sharon M. Castellino, Louis S. Constine, Cindy L. Schwartz, David Hodgson, Kara M. Kelly, Bradford S. Hoppe
Journal: Blood
Blood (2022) 140 (10): 1086–1093.
https://doi.org/10.1182/blood.2022016098
Published: 2022
Includes: Supplemental data
Journal Articles

Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children’s Oncology Group

CME Clinical Trials & Observations
Lisa Giulino-Roth, Qinglin Pei, Allen Buxton, Rizvan Bush, Yue Wu, Suzanne L. Wolden, Louis S. Constine, Kara M. Kelly, Cindy L. Schwartz, Debra L. Friedman
Journal: Blood
Blood (2021) 137 (11): 1449–1456.
https://doi.org/10.1182/blood.2020007225
Published: 2021
Includes: Supplemental data
Journal Articles

Survival Varies By Age and Histology in Classical Hodgkin Lymphoma: A Report from the Children's Oncology Group

Justine M. Kahn, MDMSc, Kara M. Kelly, MD, Qinglin Pei, PhD, Yue Wu, MS, Debra L. Friedman, MD, Tara O. Henderson, MD MPH, David C. Hodgson, MD MPH, FRCPC, Joel A. Kaplan, DO, MPH, Frank G. Keller, MD, Smita Bhatia, MDMPH, Cindy L. Schwartz, MD, Sharon M. Castellino, MD MSc
Journal: Blood
Blood (2020) 136 (Supplement 1): 24–25.
https://doi.org/10.1182/blood-2020-138796
Published: 2020
Journal Articles

Increased Tumor Specific Cytotoxic T Cell Responses and Reversion to a Favorable Cytokine Profile after Treatment in Patients with Newly Diagnosed High Risk Hodgkin Lymphoma Treated on Children's Oncology Group Trial-AHOD1331

Hema Dave, Mimi Mai, Anushree Datar, Gaye Jenkins, BS, Qinglin Pei, PhD, Yue Wu, MS, Frank G. Keller, MD, Sharon M. Castellino, MD MSc, Terzah M Horton, MD PhD, Catherine M. Bollard, MD MBChB
Journal: Blood
Blood (2020) 136 (Supplement 1): 41–42.
https://doi.org/10.1182/blood-2020-136376
Published: 2020
Journal Articles

Health-Related Quality of Life (HRQL) Trajectories during Treatment for Advanced Stage Pediatric Hodgkin Lymphoma (HL)

Susan K Parsons, MD MRP, Angie Mae Rodday, PhD MS, Rizvan Bush, MS, Qinglin Pei, PhD, Anem Waheed, MD MPH, Frank G Keller, MD, Kara M. Kelly, MD, Tara O. Henderson, MD MPH, Sharon M. Castellino, MD MSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 3587.
https://doi.org/10.1182/blood-2018-99-112664
Published: 2018
Journal Articles

Pericardial effusion in Hodgkin lymphoma: a report from the Children’s Oncology Group AHOD0031 protocol

Clinical Trials & Observations
Lianna J. Marks, Kathleen M. McCarten, Qinglin Pei, Debra L. Friedman, Cindy L. Schwartz, Kara M. Kelly
Journal: Blood
Blood (2018) 132 (11): 1208–1211.
https://doi.org/10.1182/blood-2018-02-834465
Published: 2018
Journal Articles

Survival By Race/Ethnicity in Children and Adolescents with Hodgkin Lymphoma Treated on Cooperative Group Trials in the U.S. and Canada: A Pooled Analysis of Children's Oncology Group Trials

Justine M. Kahn, MD, Kara M. Kelly, MD, Qinglin Pei, PhD, Debra L. Friedman, MD, Frank Keller, MD, Rizvan Bush, MS, Smita Bhatia, MDMPH, Tara O. Henderson, MD MPH, Cindy L. Schwartz, MD, Sharon M. Castellino, MD MSc
Journal: Blood
Blood (2017) 130 (Supplement 1): 607.
https://doi.org/10.1182/blood.V130.Suppl_1.607.607
Published: 2017
Journal Articles

Intermediate-Risk Lymphocyte-Predominant Hodgkin Lymphoma: AHOD0031: A Report from the Children's Oncology Group

Lianna J. Marks, MD, Qinglin Pei, PhD, Allen Buxton, MS, Burton Appel, MD, Kara M. Kelly, MD, Cindy L. Schwartz, MD MPH, Debra L. Friedman, MD MS
Journal: Blood
Blood (2016) 128 (22): 1814.
https://doi.org/10.1182/blood.V128.22.1814.1814
Published: 2016
Journal Articles

Subsequent Malignant Neoplasms Among Children and Adolescents with Hodgkin Lymphoma Treated with Response-Adapted Therapy: A Report from the Children's Oncology Group Study AHOD0031

Lisa Giulino-Roth, MD, Qinglin Pei, PhD, Allen Buxton, MS, Suzanne Wolden, MD, Louis S. Constine, MD, Kara M. Kelly, MD, Cindy L. Schwartz, MD MPH, Debra L. Friedman, MD MS
Journal: Blood
Blood (2016) 128 (22): 924.
https://doi.org/10.1182/blood.V128.22.924.924
Published: 2016